On Tuesday, the Food and Drug Administration (“FDA”) authorized the use of a single booster dose of the COVID-19 vaccine produced by Pfizer-BioNTech for children ages 5 through 11. FDA Commissioner Dr. Robert M. Califf said: “While it has largely been the case that COVID-19 tends to be less severe in children than adults, the omicron …
Continue reading “FDA authorizes single booster dose of COVID-19 vaccine for ages 5 through 11”